Tvardi Therapeutics, Inc. short interest in 2023
In 2023, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 9.39% of shares outstanding on 13 Jan 2023 to 4.25% on 29 Dec 2023, a change of -5.14 percentage points. The year's high was 10.65% on 15 Jun 2023 and its low 2.87% on 31 Aug 2023, averaging 7.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.81 days on 31 Jan 2023. Full history: Tvardi Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 9.39% (13 Jan 2023)
- End of year
- 4.25% (29 Dec 2023)
- Change
- -5.14 pp
- High
- 10.65% (15 Jun 2023)
- Low
- 2.87% (31 Aug 2023)
- Average
- 7.32%
- Highest days to cover
- 17.81 (31 Jan 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 9.39% | 11.88 | |
| 31 Jan 2023 | 9.97% | 17.81 | |
| 15 Feb 2023 | 10.37% | 13.94 | |
| 28 Feb 2023 | 10.22% | 14.69 | |
| 15 Mar 2023 | 9.53% | 3.80 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 9.90% | 8.20 | |
| 14 Apr 2023 | 8.97% | 8.17 | |
| 28 Apr 2023 | 9.28% | 8.75 | |
| 15 May 2023 | 9.29% | 11.55 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.47% | 4.95 | |
| 15 Jun 2023 | 10.65% | 4.82 | |
| 30 Jun 2023 | 6.90% | 1.00 | |
| 14 Jul 2023 | 7.36% | 3.81 | |
| 31 Jul 2023 | 6.43% | 4.67 | |
| 15 Aug 2023 | 4.85% | 4.15 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.87% | 3.79 | |
| 15 Sep 2023 | 4.13% | 1.73 | |
| 29 Sep 2023 | 4.56% | 3.85 | |
| 13 Oct 2023 | 5.00% | 6.36 | |
| 31 Oct 2023 | 5.49% | 6.64 | |
| 15 Nov 2023 | 6.28% | 6.98 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 6.52% | 7.80 | |
| 15 Dec 2023 | 3.99% | 3.27 | |
| 29 Dec 2023 | 4.25% | 1.15 |
See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.